Lakesha Farmer of Cencora Suggests Strategies for Ensuring Patient Access to Biosimilar Cost Savings | Asembia 2024
Managed Healthcare Executive spoke with Lakesha Farmer, Pharm.D., MBA, senior director, ION Oncology Practice Network, Cencora about how cost savings from biosimilars can be effectively passed on to patients.
Farmer shared that biosimilars were introduced to create competition and lower costs across the healthcare system.
She explained that while patients have indirectly benefited from cost savings through providers reallocating funds, there's room for improvement in providing direct savings.
She suggested implementing policies, similar to those seen with Medicare Part D, to cap out-of-pocket costs for patients.
Farmer also stressed the importance of patient-centered care and education when considering biosimilar usage to minimize disruptions and ensure optimal care.
In addition, she highlighted the need to focus on both affordability and quality of care for patients.
GLP-1 Tiering Agreement Reached, Says Optum Rx President
May 3rd 2024Health plans that use Optum Rx as their pharmacy benefit manager (PBM) will be allowed to tier their coverage of GLP-1s and still receive rebates under an agreement the PBM has reached with the manufacturers, says the PBM president. Optum officials said later that the negotiations were still ongoing,
Read More
Specialty Pharmacies Drive Cost Savings in Value-Based Care | Asembia 2024
May 2nd 2024Earlier this week at the 2024 Asembia Specialty Pharmacy Summit in Las Vegas, Managed Healthcare Executive editors spoke with Bill McElnea, vice president of population health at Shields Health Solutions, about specialty pharmacies reducing costs for patients.
Read More
